Total Funding
22
66
Total FundingPost-IPO Debt raised
Growth Score
-31 pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
54233
Perrigo is a pharmaceutical and consumer goods company that produces a variety of over-the-counter and generic prescription pharmaceuticals.
- Albert Manzone: Director, Member of Talent & Compensation CommitteePast Role: Oettinger Davidoff, President Europe
- Murray S. Kessler: President & Chief Executive OfficerPast Role: Lorillard, Chairman,President & CEO
Perrigo
About the Company
Perrigo Company plc is a leading global healthcare supplier that develops, manufactures, and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API), as well as receives royalties from Multiple Sclerosis drug Tysabri®. The company is the world's largest
manufacturer of OTC pharmaceutical products for the store brand market and an industry leader in pharmaceutical technologies. It has a presence in multiple countries and serves customers around the world.
